![Geoffrey Nichol](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Geoffrey Nichol
Direttore/Membro del Consiglio presso
TempestTx, Inc.
Patrimonio netto: 1 019 $ in data 31/05/2026
Profilo
Attualmente, Geoffrey M. Nichol occupa la posizione di Chief Medical Officer & Senior Vice President presso BioMarin Pharmaceutical, Inc. Il Dr. Nichol è anche nel consiglio di amministrazione di Millendo Therapeutics, Inc. Nichol ha precedentemente ricoperto la posizione di vicepresidente esecutivo-ricerca e sviluppo presso Sangamo Therapeutics, Inc., medico di ricerca clinica presso GlaxoSmithKline Plc, direttore medico presso Ikaria, Inc., vicepresidente senior-sviluppo del prodotto presso Medarex, Inc. e responsabile della gestione globale dei progetti presso Novartis Pharmaceuticals Corp. Geoffrey M. Nichol ha conseguito un MBA presso l'Università di Warwick e un dottorato e una laurea presso la Dunedin School of Medicine.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 27/01/2026 | 666 ( 0% ) | 1 019 $ | 31/05/2026 |
Posizioni attive di Geoffrey Nichol
| Società | Posizione | Inizio |
|---|---|---|
TempestTx, Inc.
 TempestTx, Inc. BiotechnologyHealth Technology Develops novel therapies for oncology | Direttore/Membro del Consiglio | - |
HaemaLogiX Pty Ltd.
 HaemaLogiX Pty Ltd. BiotechnologyHealth Technology Develops immunotherapies for blood cancers and B cell disorders | Direttore/Membro del Consiglio | 07/07/2022 |
Precedenti posizioni note di Geoffrey Nichol
| Società | Posizione | Fine |
|---|---|---|
| TEMPEST THERAPEUTICS, INC. | Direttore/Membro del Consiglio | 03/02/2026 |
| BIOMARIN PHARMACEUTICAL INC. | Direttore Tecnico/Scientifico/R&S | 04/10/2021 |
| SANGAMO THERAPEUTICS, INC. | Direttore Tecnico/Scientifico/R&S | 01/11/2016 |
Medarex, Inc.
 Medarex, Inc. BiotechnologyHealth Technology Provides antibody and oncology drug development services | Corporate Officer/Principal | 01/01/2009 |
Novartis Pharmaceuticals Corp.
 Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Manufactures medicines and provides healthcare solutions | Corporate Officer/Principal | 01/09/2002 |
Formazione di Geoffrey Nichol
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
69
Relazioni di 1° grado
14
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 14 |
|---|---|
Medarex, Inc.
Medarex, Inc. BiotechnologyHealth Technology Provides antibody and oncology drug development services | Health Technology |
BioMarin Pharmaceutical, Inc.
 BioMarin Pharmaceutical, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes innovative pharmaceuticals for serious diseases & medical conditions | Health Technology |
Sangamo Therapeutics, Inc.
 Sangamo Therapeutics, Inc. BiotechnologyHealth Technology Operates as a genomic medicine company | Health Technology |
Ikaria, Inc.
 Ikaria, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets therapeutics | Health Technology |
TempestTx, Inc.
TempestTx, Inc. BiotechnologyHealth Technology Develops novel therapies for oncology | Health Technology |
GSK Plc
 GSK Plc Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes vaccines and other pharmaceutical products | Health Technology |
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Manufactures medicines and provides healthcare solutions | Health Technology |
University of Warwick
 University of Warwick Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
GlaxoSmithKline LLC
 GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology Engages in research and development, manufacturing of respiratory, immunology, oncology and infectious disease medicines and vaccines | Health Technology |
AbCellera Biologics, Inc.
 AbCellera Biologics, Inc. BiotechnologyHealth Technology Discovers and develops antibody drugs & therapeutics | Health Technology |
HaemaLogiX Pty Ltd.
HaemaLogiX Pty Ltd. BiotechnologyHealth Technology Develops immunotherapies for blood cancers and B cell disorders | Health Technology |
Millendo Therapeutics, Inc.
 Millendo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
Otago Medical School
 Otago Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Tempest Therapeutics, Inc.
 Tempest Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops oncology pharmaceuticals | Health Technology |
